Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer disease

Neuroscience Letters

Volumn 222, Issue 3, 1997, Pages 183-186

  Schneider, Christoph ^a   Risser, Daniele ^a   Kirchner, Liselotte ^d   Kitzmüller, Erwin ^a   Nigel Cairns, ^b   Prast, Helmut ^c   Singewald, Nicolas ^c   Lubec, Gert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d University of Innsbruck ^*

Author keywords

Alzheimer disease; Central histaminergic system; Down syndrome; Histamine; Histamine N methyltransferase; Histidine decarboxylase; Postmortem brain analysis

Indexed keywords

CHOLINE ACETYLTRANSFERASE; HISTAMINE; HISTAMINE METHYLTRANSFERASE; HISTIDINE; HISTIDINE DECARBOXYLASE;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

AGED; AGING; ALZHEIMER DISEASE; BRAIN; CASE-CONTROL STUDIES; DOWN SYNDROME; FEMALE; FRONTAL LOBE; HISTAMINE; HISTAMINE N-METHYLTRANSFERASE; HISTIDINE; HISTIDINE DECARBOXYLASE; HUMANS; MALE; MIDDLE AGED;

EID: 0031043034     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)13379-1     Document Type: Article

References (35)

1. Airaksinen M.S., Paetau A., Paljärvi L., Reinikainen K., Riekkinen P., Suomalainen R., Panula R. Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains. Neuroscience. 9:1991;465-481.
2. Bekkers J.M. Enhancement by histamine of NMDA-mediated synaptic transmission in the hippocampus. Science. 261:1993;104-106.
3. Bischoff S., Korf J. Different localization of histidine decarboxylase and histamine-N-methyltransferase in the rat brain. Brain. Res. 141:1978;375-379.
4. Bowsher R.H., Verburg K.M., Henry D.P. Rat histamine N-methyltransferase, J. Biol. Chem. 258:1983;12215-12220.
5. Bradford M. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Cacabelos R., Yamatodani A., Niigawa H., Hariguchi S., Tada K., Nishimura T., Wada H., Brandeis L., Pearson J. Brain histamine in Alzheimer's disease. Methodol. Find. Exp. Clin. Pharmacol. 11:1989;353-360.
7. Casanova M.F., Walker L.C., Whitehouse P.J., Price D.L. Abnormalities of the nucleus basalis in Down's syndrome. Ann. Neurol. 18:1985;310-314.
8. De Almeida M.A.M.R., Izquierdo I. Memory facilitation by histamine. Arch. Int. Pharmacodyn. 283:1986;193-198.
9. De Almeida M.A.M.R., Izquierdo I. Intracerebroventricular histamine but not 48/80, causes posttraining memory facilitation in the rat. Arch. Int. Pharmacodyn. 291:1988;202-207.
10. Ehlert F.J., Roeske W.R., Yamamura H.I. Muscarinic receptors and novel strategies for the treatment of age-related brain disorders. Life Sci. 55:1994;2135-2145.
11. Epstein, C.J., Down syndrome (Trisomy 21). In C.R. Scriver, A.L. Beaudet, W.S. Sly and D. Valle (Eds.), The Metabolic and Molecular Basis of Inherited Disease, McGraw Hill, New York, 1992, pp. 749-794.
12. Fonnum F. Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem. J. 115:1969;465-472.
13. Garbarg M., Baudry M., Benda P., Schwartz J.C. Simultaneously presence of histamine-N-methyltransferase and catechol-O-methyltransferase in neuronal and glial cells in culture. Brain Res. 83:1975;538-574.
14. Godridge H., Reynolds G.P., Czudek C., Calcutt N.A., Benton M. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue. J. Neurol. Neurosurg. Psychiatry. 50:1980;775-778.
15. Goldgaber D., Lerman M.I., McBride O.W., Saffiotti U., Gajdusek D.C. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science. 235:1987;877-880.
16. Gulat-Marnay C., Lafitte A., Arrang J.M., Schwartz J.C. Regulation of histamine release and synthesis in the brain by muscarinic receptors. J. Neurochem. 52:1989;248-254.
17. Kamei C., Tasaka K. Effect of histamine on memory retrieval in old rats. Biol. Pharm. Bull. 16:1993;128-132.
18. Kamei C., Chung Y.H., Tasaka K. Influence of certain H1-blockers on the step-through active avoidance response in rats. Psychopharmacology. 102:1990;312-318.
19. Kamei C., Okumura Y., Tasaka K. Influence of histamine depletion on learning and memory recollection in rats. Psychopharmacology. 111:1993;376-382.
20. Keeling D.J., Smith J.R., Tipton K.F. A coupled assay for histidine decarboxylase: in vivo turnover of this enzyme in mouse brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 326:1984;215-222.
21. Mazurkiewicz-Kwilecki I.M., Nsonwah S. Changes in the regional brain histamine and histidine levels in postmortem brains of Alzheimer patients. Can. J. Physiol. Pharmacol. 67:1989;75-78.
22. Mann D.M.A., Yates P.O., Marcyniuk B., Rawndra C.R. Pathological evidence for neurotransmitter deficits in Down's syndrome of middle age. J. Ment. Defic. Res. 29:1985;125-135.
23. Miyazaki S., Imaizumi M., Onodera K. Ameliorating effects of histidine on scopolamine-induced learning deficits using an elevated plus-maze test in mice. Life Sci. 56:1995;1563-1570.
24. Oishi R., Adachi N., Okada K., Muroi N., Saeki K. Regulation of histamine turnover via muscarinic and nicotinic receptors in the brain. J. Neurochem. 55:1990;1899-1904.
25. Prast H., Fischer H.P., Prast M., Philippu A. In vivo modulation of histamine release by autoreceptors and muscarinic acetylcholine receptors in rat anterior hypothalamus. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:1994;599-604.
26. Prast H., Gujrati V., Walser S., Philippu A. Histamine, histidine decarboxylase and histamine-N-methyltransferase in brain areas of spontaneously hypertensive rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 338:1988;573-578.
27. Prast H., Fischer H., Philippu A. Release of acetylcholine in the ventral striatum is influenced by histamine receptors. Agent Actions. 41:1994;C85-C86.
28. Price D.L., Whitehouse P.J., Struble R.G., Coyle S.D., Clark A.W., Delong M.R., Cork L.C., Hedreen J.C. Alzheimer's disease in Down's syndrome. Ann. N. Y. Acad. Sci. 396:1982;145-164.
29. Robakis N.K., Wisniewski H.M., Jenkins E.C., Devine Gage E.A., Houck G.E., Xao X.L., Ramakrishna N., Wolfe G., Sliverman W.P., Brown W.T. Chromosome 21q21 sublocalisation of gene encoding beta amyloid peptide in cerebral vessels and neuritic (senile) plaques of people with Alzheimer disease and Down syndrome. Lancet. 1:1987;384-385.
30. Singewald N., Guo L., Philippu A. In vivo release patterns and cardiovascular properties of inhibitory and excitatory amino acids in the hypothalamus. Amino Acids. 8:1995;47-58.
31. Tanzi R.E., Gusella J.F., Watkins P.C., Bruns G.A., St. George Hyslop P., Van Keuren M.L., Patterson D., Pagan S., Kurnit D.M., Neve R.L. Amyloid B protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science. 235:1987;880-884.
32. Teyler, T.J., Long-term potentiation and memory, Int. J. Neurol., 21/22 (1987-1988) 163-171.
33. Tierney M.C., Fisher R.H., Lewis A.J., Zorzitto M.L., Snow W.G., Reid D.W., Nieuwstraten P. The NICDA-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease. Neurology. 38:1989;359-364.
34. Wisniewski K.E., Wisniewski H.M., Wen G.Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down syndrome. Ann. Neurol. 17:1985;278-282.
35. Yates C.M., Simpson J., Maloney A.J.F., Gordon A., Reid G.A. Alzheimer-like cholinergic deficiency in Down's syndrome. Lancet. 2:1980;775.